61 – 80 of 137
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Developing stem cell therapies for Parkinson's disease : waiting until the time is right
(
- Contribution to journal › Article
-
Mark
The Central Clock in Patients With Parkinson Disease — Reply
(
- Contribution to journal › Letter
-
Mark
Which patients with Parkinson's disease participate in clinical trials? : One centre's experiences with a new cell based therapy trial (TRANSEURO)
(
- Contribution to journal › Article
-
Mark
Mild cognitive impairment and Parkinson's disease - something to remember
(
- Contribution to journal › Article
-
Mark
Modelling of a targeted nanotherapeutic 'stroma' to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt-β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease : ICICLE-PD study
(
- Contribution to journal › Article
-
Mark
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants
(
- Contribution to journal › Article
-
Mark
Targeting impulsivity in Parkinson's disease using atomoxetine
(
- Contribution to journal › Article
-
Mark
Sleep and circadian rhythm regulation in early Parkinson disease
(
- Contribution to journal › Article
-
Mark
Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life
(
- Contribution to journal › Article
-
Mark
Treating Parkinson's disease in the 21st century : can stem cell transplantation compete?
(
- Contribution to journal › Article
-
Mark
Quality of life and mild cognitive impairment in early Parkinson's disease : does subtype matter?
(
- Contribution to journal › Article
-
Mark
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease : a dose escalation, open-label, phase 1/2 trial
(
- Contribution to journal › Article
-
Mark
Characterizing mild cognitive impairment in incident Parkinson disease : the ICICLE-PD study
(
- Contribution to journal › Article
-
Mark
Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Predictors of Parkinson's disease dementia : towards targeted therapies for a heterogeneous disease
(
- Contribution to journal › Article
-
Mark
Health-related quality of life in early Parkinson's disease : the impact of nonmotor symptoms
(
- Contribution to journal › Article
-
Mark
The incidence of Parkinson's disease in the North-East of England
(
- Contribution to journal › Article
-
Mark
Chapter 22 - Rodent Models of Treatment-Related Complications in Parkinson Disease
2014) p.373-386(
- Chapter in Book/Report/Conference proceeding › Book chapter